Form 4: Quest Diagnostics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Mark E Delaney, SVP & Chief Commercial Officer of Quest Diagnostics Inc, reported a transaction in 34 shares of common stock on July 22, 2026.
Summary
- Small acquisition: acquired 34 Common Stock at $206.81 ($7,031) on July 22, 2026; holds 11,935 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark E Delaney — Officer (SVP & Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Small acquisition | Common Stock | 34 | $207 | $7.0K | 11,935 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Small acquisition (34 shares) |
Keywords
insider transaction, Form 4, DGX, QUEST DIAGNOSTICS INC, neutral, Mark E Delaney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.